Amplify Partners — 2022 Investments
5 investments dated 2022 · listed companies and verified rows first · show all
Exai Bio develops an RNA-based liquid biopsy platform that uses novel RNA biomarkers and AI to detect cancer from a blood draw.
AI & Machine LearningBiotechDigital HealthPalo Alto, US
Board seatHani Goodarzi· per SEC Form D · $71.5M raise · filed Oct 2022
Longmont, US
Board seatSunil Dhaliwal· per SEC Form D · $22M raise · filed Oct 2022
New York, US
Board seatSunil Dhaliwal· per SEC Form D · $50M raise · filed Dec 2022
Co-investorsRunway
Kwil provides a decentralized database and programming language for Web3 projects, enabling technical implementation of data ownership and privacy controls.
Cloud ComputingCrypto & Web3Data & InfrastructureAustin, US
Brennan Lamey(Executive Officer, Director)inLuke Lamey(Executive Officer, Director)Luis Gruson(Executive Officer, Director)
Co-investorsAlleyCorpNxGenAlley Robotics VenturesBlockchange VenturesDigital Currency GroupFJ Labs
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
